MiNK Therapeutics, Inc. (INKT)
Largest Insider Buys in Sector
INKT Stock Price History Chart
INKT Stock Performance
About MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.
Insider Activity of MiNK Therapeutics, Inc.
Over the last 12 months, insiders at MiNK Therapeutics, Inc. have bought $368,144 and sold $0 worth of MiNK Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at MiNK Therapeutics, Inc. have bought $5.86M and sold $94,850 worth of stock each year.
Highest buying activity among insiders over the last 12 months: AGENUS INC (10 percent owner) — $368,144.
The last purchase of 429 shares for transaction amount of $472 was made by AGENUS INC (10 percent owner) on 2023‑10‑16.
List of Insider Buy and Sell Transactions, MiNK Therapeutics, Inc.
| 2023-10-16 | AGENUS INC | 10 percent owner | 429 0.0012% | $1.10 | $472 | -12.35% | ||
| 2023-10-13 | AGENUS INC | 10 percent owner | 19,373 0.0561% | $1.10 | $21,310 | -12.34% | ||
| 2023-10-12 | AGENUS INC | 10 percent owner | 3,173 0.0089% | $1.10 | $3,488 | -15.42% | ||
| 2023-10-04 | AGENUS INC | 10 percent owner | 15,001 0.0465% | $1.09 | $16,380 | -15.11% | ||
| 2023-08-29 | AGENUS INC | 10 percent owner | 29,678 0.0826% | $1.52 | $45,016 | -37.51% | ||
| 2023-08-28 | AGENUS INC | 10 percent owner | 12,808 0.0371% | $1.45 | $18,570 | -31.73% | ||
| 2023-08-24 | AGENUS INC | 10 percent owner | 170,244 0.4482% | $1.54 | $262,908 | -36.54% | ||
| 2023-05-11 | AGENUS INC | 10 percent owner | 23,361 0.0606% | $1.43 | $33,348 | -34.57% | ||
| 2023-05-10 | AGENUS INC | 10 percent owner | 22,065 0.0649% | $1.51 | $33,296 | -29.80% | ||
| 2023-05-05 | Sale | ARMEN GARO H | director | 100,000 0.1767% | $0.95 | $94,850 | -31.96% | |
| 2023-05-05 | AGENUS INC | 10 percent owner | 100,200 0.1772% | $0.95 | $95,100 | -31.96% | ||
| 2023-05-05 | AGENUS INC | 10 percent owner | 200 0.0005% | $1.25 | $250 | -31.96% | ||
| 2023-05-04 | AGENUS INC | 10 percent owner | 21,473 0.0618% | $1.22 | $26,246 | -13.80% | ||
| 2023-05-03 | AGENUS INC | 10 percent owner | 128,689 0.3494% | $1.08 | $138,843 | -7.69% | ||
| 2023-05-02 | ARMEN GARO H | director | 100,000 0.3138% | $0.95 | $94,850 | +21.35% | ||
| 2022-07-18 | WIINBERG ULF | 3,339 0.0098% | $1.33 | $4,438 | +60.45% | |||
| 2021-10-19 | AGENUS INC | 10 percent owner | 1.4M 4.2248% | $12.00 | $16.8M | -79.46% |
Insider Historical Profitability
| AGENUS INC | 10 percent owner | 21772863 63.074% | $0.89 | 14 | 0 | <0.0001% |
| ARMEN GARO H | director | 1866400 5.4068% | $0.89 | 1 | 1 | +21.35% |
| WIINBERG ULF | 281639 0.8159% | $0.89 | 1 | 0 | +60.45% |
Institutional Investor Ownership
| The Vanguard Group | $212,708.00 | 0.6 | 234,182 | 0% | +$0 | <0.0001 | |
| Longbow Finance Sa | $151,383.00 | 0.42 | 166,666 | 0% | +$0 | 0.02 | |
| Renaissance Technologies | $96,000.00 | 0.27 | 105,228 | +14.33% | +$12,030.56 | <0.0001 | |
| Geode Capital Management | $80,727.00 | 0.23 | 88,856 | -1.45% | -$1,188.34 | <0.0001 | |
| BlackRock | $69,165.00 | 0.19 | 76,148 | -0.4% | -$280.66 | <0.0001 | |
| CAPTRUST | $49,313.00 | 0.14 | 54,291 | 0% | +$0 | <0.0001 | |
| Hightower Advisors | $43,000.00 | 0.13 | 50,880 | -0.12% | -$51.55 | <0.0001 | |
| Susquehanna International Group | $27,095.00 | 0.08 | 29,831 | New | +$27,095.00 | <0.0001 | |
| State Street | $23,250.00 | 0.07 | 25,597 | -0.4% | -$93.56 | <0.0001 | |
| Citadel Advisors LLC | $18,901.00 | 0.05 | 20,809 | -50.62% | -$19,376.05 | <0.0001 | |
| Millennium Management LLC | $18,254.00 | 0.05 | 20,097 | New | +$18,254.00 | <0.0001 | |
| Goldman Sachs | $14,199.00 | 0.04 | 15,632 | -22.06% | -$4,019.36 | <0.0001 | |
| Northern Trust | $10,082.00 | 0.03 | 11,099 | -0.03% | -$2.73 | <0.0001 | |
| Tower Research Capital | $10,042.00 | 0.03 | 11,060 | +1.07% | +$106.23 | <0.0001 | |
| Wells Fargo | $10,006.00 | 0.03 | 11,017 | -4.42% | -$462.29 | <0.0001 | |
| UBS | $2,935.00 | 0.01 | 3,232 | -35.94% | -$1,646.40 | <0.0001 | |
| Bank of America | $2,849.00 | 0.01 | 3,137 | -84.89% | -$16,004.17 | <0.0001 | |
| Artal Group S A | $1,740.00 | 0.01 | 1,916 | 0% | +$0 | <0.0001 | |
| Qube Research & Technologies | $1,763.00 | 0.01 | 1,941 | 0% | +$0 | <0.0001 | |
| CalSTRS | $1,406.00 | <0.01 | 1,548 | 0% | +$0 | <0.0001 | |
| Covestor Ltd | $1,000.00 | <0.01 | 1,055 | -1.31% | -$13.27 | <0.01 | |
| Advisor Group Holdings Inc | $832.00 | <0.01 | 920 | +215.07% | +$567.93 | <0.0001 | |
| Morgan Stanley | $545.00 | <0.01 | 600 | -86.63% | -$3,530.69 | <0.0001 | |
| Chilton Capital Management LLC | $281.00 | <0.01 | 309 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $97.00 | <0.01 | 107 | 0% | +$0 | <0.0001 | |
| Key Financial, Inc. | $39.00 | <0.01 | 43 | 0% | +$0 | <0.0001 | |
| Northwestern Mutual Wealth Management Co | $168.00 | <0.01 | 185 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 124 | -80.95% | -$0 | <0.0001 | |
| Sittner Nelson Llc | $53.00 | <0.01 | 58 | 0% | +$0 | <0.0001 | |
| LifeSteps Financial | $25.00 | <0.01 | 28 | New | +$25.00 | <0.0001 | |
| RhumbLine Advisers | $43.00 | <0.01 | 48 | New | +$43.00 | <0.0001 | |
| Game Plan Financial Advisors Llc | $154.00 | <0.01 | 170 | 0% | +$0 | <0.0001 | |
| Allworth Financial Lp | $2.00 | <0.01 | 2 | 0% | +$0 | <0.0001 | |
| Harbor Investment Advisory | $5.00 | <0.01 | 5 | 0% | +$0 | <0.0001 |